LeCroy Corp (LCRY) Tops Q4 EPS by 3c, Posts Inline Q1 and FY12 Guidance
Get Alerts LCRY Hot Sheet
Price: $14.31 --0%
Financial Fact:
Write-off of bank deferred financing fees: 0
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Write-off of bank deferred financing fees: 0
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
LeCroy Corp (NASDAQ: LCRY) reported Q4 EPS of $0.31, $0.03 better than the analyst estimate of $0.28. Revenue for the quarter came in at $47.5 million versus the consensus estimate of $47.25 million.
LeCroy Corp sees Q1 2012 EPS of $0.23-$0.26, versus the consensus of $0.26. LeCroy Corp sees Q1 2012 revenue of $47.5 million, versus the consensus of $46.5 million.
LeCroy Corp sees FY2012 EPS of $1.15-$1.20, versus the consensus of $1.21. LeCroy Corp sees FY2012 revenue of $195-$200 million, versus the consensus of $200 million.
LeCroy Corp sees Q1 2012 EPS of $0.23-$0.26, versus the consensus of $0.26. LeCroy Corp sees Q1 2012 revenue of $47.5 million, versus the consensus of $46.5 million.
LeCroy Corp sees FY2012 EPS of $1.15-$1.20, versus the consensus of $1.21. LeCroy Corp sees FY2012 revenue of $195-$200 million, versus the consensus of $200 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share